Assessing the quality of patient-reported outcome measurements for gynecological cancers: a systematic review
Charlotte Moss(Southampton General Hospital), Mieke Van Hemelrijck(Ghent University Hospital), Katharina Beyer, Elena Silvia Sisca(Vita-Salute San Raffaele University), Maria Monica Ratti(Vita-Salute San Raffaele University), Teresa Guerrero Urbano(Guy's and St Thomas' NHS Foundation Trust), Nicholas Wood, Ingrid White(Guy's and St Thomas' NHS Foundation Trust), Monika Sztankay(Innsbruck Medical University), Benjamin Taylor(Guy's and St Thomas' NHS Foundation Trust), Lisa M. Wintner(Universität Innsbruck), Steven MacLennan(University of Aberdeen), Alexandra Derevianko(Vita-Salute San Raffaele University), Rebecca Kristeleit(Guy's and St Thomas' NHS Foundation Trust), Louis Fox(King's College London), Ana Montes(Guy's and St Thomas' NHS Foundation Trust)
Cited by 2
Related Papers
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study
|The Lancet Oncology|2021|614
Avelumab alone or in combination with chemotherapy versus chemotherapy alone in platinum-resistant or platinum-refractory ovarian cancer (JAVELIN Ovarian 200): an open-label, three-arm, randomised, phase 3 study
|The Lancet Oncology|2021|401
Prevalence and demography of transsexualism in Belgium
|European Psychiatry|2007|306